Remedium Lifecare Ltd

Remedium Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Remedium Lifecare Ltd

₹ 0.91 4.60%
26 Jun 4:01 p.m.
remlife.com BSE: 539561
About

Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products

Key Points

Business Overview:[1]
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets

Website BSE
  • Market Cap ₹ 80.3 Cr.
  • Current Price ₹ 0.91
  • High / Low ₹ 63.4 / 0.80
  • Stock P/E 52.5
  • Book Value ₹ 0.48
  • Dividend Yield 0.00 %
  • ROCE 1.39 %
  • ROE 3.55 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 51.2%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 1.11%
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.10.8 Cr.
  • Company has high debtors of 969 days.
  • Working capital days have increased from 647 days to 1,941 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
40.29 99.33 158.45 176.48 75.58 330.46 468.57 1,834.18 1,408.49 77.70 25.08 38.15 81.57
40.88 92.72 156.31 174.95 78.48 323.18 462.23 1,779.48 1,443.51 77.31 20.62 43.63 82.75
Operating Profit -0.59 6.61 2.14 1.53 -2.90 7.28 6.34 54.70 -35.02 0.39 4.46 -5.48 -1.18
OPM % -1.46% 6.65% 1.35% 0.87% -3.84% 2.20% 1.35% 2.98% -2.49% 0.50% 17.78% -14.36% -1.45%
0.00 0.00 0.06 0.02 0.00 0.00 4.08 14.12 2.89 1.89 0.82 7.43 0.66
Interest 0.11 0.00 0.00 0.02 -0.10 0.00 0.00 0.03 3.85 0.00 2.81 0.88 1.59
Depreciation 0.02 0.11 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Profit before tax -0.72 6.50 2.19 1.52 -2.81 7.27 10.41 68.78 -35.99 2.27 2.46 1.06 -2.12
Tax % 62.50% 0.00% 0.00% 0.00% 70.11% 27.79% 37.27% 33.38% 49.24% 27.75% 27.64% 27.36% 24.53%
-1.16 6.50 2.19 1.52 -4.78 5.25 6.53 45.82 -53.72 1.64 1.78 0.76 -2.64
EPS in Rs -0.01 0.07 0.02 0.02 -0.05 0.06 0.07 0.51 -0.60 0.02 0.02 0.01 -0.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 2 4 1 0 0 3 90 505 510 4,040 222
1 2 4 1 0 0 2 89 503 502 4,006 224
Operating Profit 0 -0 -0 -0 0 -0 0 1 2 8 34 -2
OPM % 3% -8% -8% -7% 0% -44% 14% 1% 0% 2% 1% -1%
0 1 0 0 0 0 0 0 0 0 21 11
Interest 0 0 0 0 0 0 0 0 0 0 5 5
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 1 0 0 0 0 0 1 2 7 50 4
Tax % 50% 21% 0% 0% 0% 100% 24% 26% 29% 27% 35% 58%
0 1 0 0 0 0 0 0 1 5 33 2
EPS in Rs 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.06 0.37 0.02
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 59%
5 Years: 138%
3 Years: -24%
TTM: -94%
Compounded Profit Growth
10 Years: 10%
5 Years: 40%
3 Years: 12%
TTM: -95%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: -38%
1 Year: -98%
Return on Equity
10 Years: 41%
5 Years: 48%
3 Years: 51%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 4 4 4 4 4 10 40
Reserves -0 -1 -1 -1 -1 -1 -0 0 1 7 33 3
1 0 0 0 0 0 0 10 0 0 58 1,141
1 3 2 0 0 0 1 24 219 1,144 1,847 355
Total Liabilities 6 6 5 3 3 4 4 39 224 1,154 1,948 1,540
2 1 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
4 4 5 3 3 4 4 38 224 1,154 1,948 1,540
Total Assets 6 6 5 3 3 4 4 39 224 1,154 1,948 1,540

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 -1 0 -0 -0 -0 -10 11 20 -74 -1,079
0 1 0 0 1 -0 -0 -0 -0 0 0
-0 -0 0 0 0 0 10 -11 -0 54 1,078
Net Cash Flow -0 0 0 -0 1 -0 -0 1 20 -20 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2007 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 120 341 265 596 2,117 319 189 96 46 123 83 969
Inventory Days 1,129 243 78 0 0 5 12 455
Days Payable 102 438 129 62 65 542
Cash Conversion Cycle 1,147 146 214 596 2,117 319 189 96 46 67 30 882
Working Capital Days 566 107 200 524 2,159 4,745 323 54 2 -8 9 1,941
ROCE % 1% 1% 0% 1% 1% 11% 7% 18% 103% 100% 1%

Shareholding Pattern

Numbers in percentages

37 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11%
0.00% 0.00% 0.00% 0.00% 0.04% 0.08% 0.04% 0.04% 0.00% 0.00% 0.00% 0.00%
98.89% 98.88% 98.88% 98.88% 98.84% 98.81% 98.86% 98.85% 98.89% 98.89% 98.89% 98.89%
No. of Shareholders 6226046227051,7303,9883,85915,58726,46467,40473,6371,10,422

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports